“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
A five-year holding period can reveal far more about an investment than short-term price moves. For investors evaluating The Cigna Group, the key question is how Cigna stock performed when measured on a total return basis, including both share-price appreciation and reinvested dividends. Based on the figures below, a $10,000 investment in The Cigna Group (NYSE: CI) made on 10/06/2021 would have grown to $14,645.73 by 10/05/2026.
Cigna 5-Year Total Return at a Glance
| Start date: | 10/06/2021 |
|
|||
| End date: | 10/05/2026 | ||||
| Start price/share: | $203.25 | ||||
| End price/share: | $271.29 | ||||
| Starting shares: | 49.20 | ||||
| Ending shares: | 53.99 | ||||
| Dividends reinvested/share: | $26.72 | ||||
| Total return: | 46.46% | ||||
| Average annual return: | 7.93% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $14,645.73 | ||||
The result is straightforward: over this five-year period, Cigna stock produced a 46.46% total return, or 7.93% annualized, turning a $10,000 initial investment into $14,645.73. Those figures include dividend reinvestment, which is important because total return provides a more complete measure of shareholder outcomes than price appreciation alone. [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
What Drove the Return
Cigna’s five-year performance came from two sources:
- Share-price appreciation: the stock rose from $203.25 to $271.29.
- Dividends: the company paid a cumulative $26.72 per share over the period, and reinvesting those payments increased the share count from 49.20 to 53.99.
That distinction matters. A stock can post a respectable total return even if capital gains are moderate, provided the dividend stream is consistent and reinvestment adds incremental compounding. In Cigna’s case, the increase in ending shares illustrates how dividend reinvestment contributed meaningfully to the final investment value.
Why Total Return Matters for Health Insurers
For large managed-care and health-services companies such as The Cigna Group, investment results are often shaped by a combination of earnings growth, capital allocation, and the market’s view of reimbursement, medical cost trends, regulation, and pharmacy benefit economics. That makes total return analysis especially useful. It captures not just the market’s changing valuation of the business, but also the cash returned to shareholders along the way.
Cigna is not typically viewed as a high-yield stock. Instead, its shareholder return profile has generally depended on a balance of business performance, disciplined capital deployment, and a modest but meaningful dividend. That helps explain why dividend reinvestment improved the outcome without dominating it.
Current Yield and Yield on Cost
Based on the most recent annualized dividend rate of $6.24 per share, CI has a current yield of approximately 2.30%. Another useful reference point is yield on cost, which compares the current annualized dividend to the original purchase price rather than the current market price.
Using the 10/06/2021 purchase price of $203.25 per share, the current $6.24 annualized dividend equates to a yield on cost of about 3.07%. That figure is distinct from current yield: current yield reflects what a new buyer receives at today’s share price, while yield on cost shows how the income stream has grown relative to the original entry price.
Key Takeaways
In concise terms, the five-year Cigna investment outcome can be summarized as follows:
- $10,000 invested in CI on 10/06/2021 grew to $14,645.73 by 10/05/2026.
- Total return was 46.46% with dividends reinvested.
- Annualized return was 7.93%.
- Dividend reinvestment increased the share count from 49.20 to 53.99.
- The current annualized dividend rate of $6.24 implies a current yield near 2.30%.
The broader point is that a medium-term holding period can produce a materially different picture than day-to-day market volatility suggests. In this case, Cigna stock delivered a positive and reasonably steady compounding result over five years, with dividends providing an additional layer of return alongside share-price gains.
Here’s one more notable investment quote before you go:
“In trading you have to be defensive and aggressive at the same time. If you are not aggressive, you are not going to make money, and if you are not defensive, you are not going to keep money.” — Ray Dalio
